M. Wainberg

M. Wainberg, C. Tremblay, S. Walmsley, 2010, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1

M. Wainberg, H. Salomón, Q. Gao, 2005, Archives of Virology.

Lamivudine Can Exert a Modest Antiviral Effect against Human Immunodeficiency Virus Type 1 Containing the M184V Mutation

M. Wainberg, B. Brenner, Y. Quan, 2003, Antimicrobial Agents and Chemotherapy.

Selection of Resistance-Conferring Mutations in HIV-1 by the Nucleoside Reverse Transcriptase Inhibitors (+/-)dOTC and (+/-)dOTFC

M. Wainberg, H. Salomón, Maureen Oliveira, 2000, Antiviral chemistry & chemotherapy.

Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants Resistant to the (+) and (−) Enantiomers of 2′-Deoxy-3′-Oxa-4′-Thio-5-Fluorocytidine

M. Wainberg, H. Salomón, T. Mansour, 2000, Antimicrobial Agents and Chemotherapy.

Selection and Characterization of HIV-1 Variants Resistant to the (+) and (-) Enantiomers of 2′-Deoxy-3′-Oxa-4′-Thiocytidine (Dotc)

M. Wainberg, H. Salomón, J. Bédard, 1998, Antiviral therapy.

The Thiocarboxanilide Nonnucleoside Inhibitor UC781 Restores Antiviral Activity of 3′-Azido-3′-Deoxythymidine (AZT) against AZT-Resistant Human Immunodeficiency Virus Type 1

M. Wainberg, M. Parniak, G. Borkow, 1999, Antimicrobial Agents and Chemotherapy.

Human Immunodeficiency Virus Proviral DNA from Peripheral Blood and Lymph Nodes Demonstrates Concordant Resistance Mutations to Zidovudine (Codon 215) and Didanosine (Codon 74)

M. Wainberg, O. Weislow, D. Mayers, 1998 .

Diminished HIV-1 Sensitivity to Stavudine in Patients on Prolonged Therapy Occurs Only at Low Levels and Cannot be Attributed to Any Single Amino Acid Substitution in Reverse Transcriptase

J. Montaner, M. Wainberg, H. Salomón, 1998, Antiviral therapy.

Resistance Profile of a Novel 2′, 3′ - Dideoxynucleoside Analog with Activity Against HIV-1

M. Wainberg, H. Salomón, T. Mansour, 1997 .

Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

M. Wainberg, H. Salomón, M. Slater, 1997, Antimicrobial agents and chemotherapy.

The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors

M. Wainberg, Y. Kew, H. Salomón, 1996, Antimicrobial agents and chemotherapy.

Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1

M. Wainberg, C. Morrow, Y. Quan, 1996, Journal of virology.

Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively

M. Wainberg, M. Parniak, Y. Quan, 1996, Journal of virology.

Targeting HIV reverse transcriptase in novel ways

M. Wainberg, Z. Gu, 1995, Nature Medicine.

Effects of Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 in Cell-free Recombinant Reverse Transcriptase Assays (*)

M. Wainberg, E. Arts, Zhou Li, 1995, The Journal of Biological Chemistry.

Host Cell Dependence of Human Immunodeficiency Virus Type-1 Drug Resistance Profiles and Tissue Culture Selection Patterns

M. Wainberg, H. Salomón, Q. Gao, 1995 .

Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells.

M. Wainberg, J. Hiscott, Z. Gu, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

M. Wainberg, Q. Gao, J. Hiscott, 1993, Antimicrobial Agents and Chemotherapy.

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

M. Wainberg, B. Spira, J. Kraus, 1991, Antimicrobial Agents and Chemotherapy.

Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs

M. Wainberg, Q. Gao, M. Tremblay, 1991, Antimicrobial Agents and Chemotherapy.

Clinical significance and characterization of AZT-resistant strains of HIV-1.

J. Montaner, M. Wainberg, Q. Gao, 1991, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Inhibitors Rilpivirine and Etravirine Nonnucleoside Reverse Transcriptase Defining Patterns of Resistance to Interactions with the M184I Mutation on HIV-1 Reverse Transcriptase and Their Effect of Mutations at Position E138 in

M. Wainberg, S. Colby-Germinario, M. McCallum, 2014 .

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

M. Wainberg, D. Moisi, S. Colby-Germinario, 2012, Antimicrobial Agents and Chemotherapy.

HIV-1 subtype C viruses rapidly develop K65R

M. Wainberg, B. Brenner, M. Mine, 2006, Retrovirology.

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.

M. Wainberg, M. Klein, J. Martínez-Cajas, 2008, AIDS reviews.

Latent HIV-1 Can Be Reactivated by Cellular Superinfection in a Tat-Dependent Manner, Which Can Lead to the Emergence of Multidrug-Resistant Recombinant Viruses

M. Wainberg, D. Donahue, Richard Sloan, 2013, Journal of Virology.

AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.

M. Wainberg, M. Tremblay, R. Rooke, 1990, Virology.

Clinical correlates and molecular basis of HIV drug resistance.

J. Singer, M. Wainberg, E. Arts, 1993, Journal of acquired immune deficiency syndromes.

Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine

J. Montaner, M. Wainberg, D. Cooper, 2001, AIDS.

Two standards of care for HIV: Why are Africans being short-changed?

M. Wainberg, 2009, Retrovirology.

Prevalence of the K65R resistance reverse transcriptase mutation in different HIV‐1 subtypes in Israel

M. Wainberg, D. Turner, E. Kedem, 2009, Journal of medical virology.

Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C.

M. Wainberg, B. Brenner, D. Moisi, 2009, The Journal of infectious diseases.

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

T. F. Rinke de Wit, T. Hallett, M. Wainberg, 2017, The lancet. HIV.

Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.

M. Wainberg, C. Liang, D. Donahue, 2011, Virology.

Tetherin restricts direct cell-to-cell infection of HIV-1

M. Wainberg, C. Liang, T. Bar-Magen, 2010, Retrovirology.

Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?

M. Wainberg, M. Youle, 2003, AIDS.

Time for gender mainstreaming in editorial policies

Q. A. Karim, M. Wainberg, P. Sow, 2011, Journal of the International AIDS Society.

New pandemics: HIV and AIDS, HCV and chronic hepatitis, Influenza virus and flu

M. Wainberg, J. Dubuisson, J. Darlix, 2007, Retrovirology.

Promote HIV Chemoprophylaxis Research, Don't Prevent It

John P. Moore, M. Wainberg, S. Buchbinder, 2005, Science.

The long-term effects of anti-retroviral protease inhibitors on sugar transport in L6 cells.

M. Wainberg, R. Germinario, S. Colby-Germinario, 2003, The Journal of endocrinology.

The long-term effects of anti-retroviral protease inhibitors on sugar transport in L 6 cells

M. Wainberg, R. Germinario, S. Colby-Germinario, 2003 .

Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations

M. Wainberg, B. Brenner, Eugene L. Asahchop, 2011, Journal of Virology.

Can the further clinical development of bevirimat be justified?

Jan Albert, M. Wainberg, J. Albert, 2010, AIDS.

Will drug resistance against dolutegravir in initial therapy ever occur?

M. Wainberg, Yingshan Han, 2015, Front. Pharmacol..

Effect of HIV-1 Integrase Resistance Mutations When Introduced into SIVmac239 on Susceptibility to Integrase Strand Transfer Inhibitors

M. Wainberg, P. Quashie, Said A Hassounah, 2014, Journal of Virology.

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance

M. Wainberg, 2012, Scientifica.

Resistance to HIV integrase inhibitors

M. Wainberg, P. Quashie, T. Mesplède, 2012, Current opinion in HIV and AIDS.

Differences among HIV-1 subtypes in drug resistance against integrase inhibitors.

M. Wainberg, Yingshan Han, T. Mesplède, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor

M. Wainberg, Wei‐Lie Xiao, Han-Dong Sun, 2015, Antiviral chemistry & chemotherapy.

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.

M. Wainberg, C. Petropoulos, B. Brenner, 2015, The Journal of antimicrobial chemotherapy.

HIV-1 subtype B integrase confers low-level

M. Wainberg, T. Mesplède, Vincent Cutillas, 2014 .

Integrase strand transfer inhibitors in the management of HIV-positive individuals

M. Wainberg, P. Quashie, T. Mesplède, 2014, Annals of medicine.

Resistance Substitutions in HIV-1 Integrase G118R-Linked Dolutegravir Drug Biochemical Analysis of the Role of

M. Wainberg, P. Quashie, Nathan Osman, 2014 .

The Effect of HIV-1 Integrase Resistance Mutations when Introduced into 1

M. Wainberg, P. Quashie, Said A Hassounah, 2014 .

Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors.

M. Wainberg, O. Delelis, E. Deprez, 2013, Antiviral research.

Isolation of drug-resistant mutant HIV variants using tissue culture drug selection.

M. Wainberg, B. Brenner, Maureen Oliveira, 2009, Methods in molecular biology.

Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection

M. Wainberg, M. Ntemgwa, B. Brenner, 2009, Antimicrobial Agents and Chemotherapy.

Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs

M. Wainberg, B. Brenner, D. Moisi, 2005, Journal of the International AIDS Society.

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

M. Wainberg, D. Donahue, 2013, Retrovirology.

The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline.

M. Wainberg, S. Colby-Germinario, Said A Hassounah, 2015, The Journal of antimicrobial chemotherapy.

Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR

N. Sonenberg, M. Wainberg, M. Mathews, 1997, Journal of virology.

Effects of mutations in Pr160gag-pol upon tRNA(Lys3) and Pr160gag-plo incorporation into HIV-1.

M. Wainberg, I. Lowy, J. Mak, 1997, Journal of molecular biology.

The Role of Nucleocapsid and U5 Stem/A-Rich Loop Sequences in tRNA3Lys Genomic Placement and Initiation of Reverse Transcription in Human Immunodeficiency Virus Type 1

M. Wainberg, J. Darlix, L. Kleiman, 1998, Journal of Virology.

Tetherin and Its Viral Antagonists

M. Wainberg, C. Liang, B. Kuhl, 2011, Journal of Neuroimmune Pharmacology.

The 16th International Conference on AIDS: Will It Leave a Legacy?

H. Gayle, M. Wainberg, 2007, Journal of the International AIDS Society.

Eurifoloids A-R, structurally diverse diterpenoids from Euphorbia neriifolia.

M. Wainberg, Yingshan Han, J. Yue, 2014, Journal of natural products.

Gender-sensitive reporting in medical research

J. Montaner, M. Wainberg, K. Squires, 2012, Journal of the International AIDS Society.

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

M. Wainberg, C. Delaugerre, C. Tremblay, 2017, The lancet. HIV.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

J. Montaner, M. Wainberg, D. Cooper, 1998, JAMA.

Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens

M. Wainberg, D. Dickinson, M. Mine, 2009, Journal of the International AIDS Society.

Inhibition of NF‐&kgr;B‐dependent HIV‐1 replication by the marine natural product bengamide A

M. Wainberg, David E. Williams, R. Andersen, 2018, Antiviral research.

The effects of the W 153 L substitution in HIV reverse transcriptase on viral replication and 1 drug resistance to multiple categories of reverse transcriptase inhibitors 2

M. Wainberg, S. Colby-Germinario, Hong-tao Xu, 2014 .

Roles of the K 101 E Substitution in HIV-1 Reverse Transcriptase in Resistance to 1 Rilpivirine and other Non-Nucleoside Reverse Transcriptase Inhibitors 2 3

M. Wainberg, C. Petropoulos, S. Colby-Germinario, 2013 .

Identification of resveratrol analogs as potent anti‐dengue agents using a cell‐based assay

M. Wainberg, P. Crooks, Yingshan Han, 2017, Journal of medical virology.

Flueggether A and Virosinine A, Anti-HIV Alkaloids from Flueggea virosa.

M. Wainberg, C. Luo, K. Zhu, 2015, Organic letters.

Trichiconins A-C, limonoids with new carbon skeletons from Trichilia connaroides.

M. Wainberg, Yingshan Han, J. Yue, 2014, Organic letters.

Heat Shock Protein-Based Therapeutic Strategies Against Human Immunodeficiency Virus

M. Wainberg, B. Brenner, 1999 .

Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection.

M. Wainberg, B. Brenner, 1999, Infectious diseases in obstetrics and gynecology.

Reverse Transcriptase Inhibitors Can Selectively Block the Synthesis of Differently Sized Viral DNA Transcripts in Cells Acutely Infected with Human Immunodeficiency Virus Type 1

M. Wainberg, L. Rong, C. Liang, 1999, Journal of Virology.

Alcoholism and rapid progression to AIDS after seroconversion.

M. Wainberg, I. Fong, W. Chia, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor

M. Wainberg, P. Quashie, Yingshan Han, 2015, PloS one.

The impact of the M184V substitution on drug resistance and viral fitness.

M. Wainberg, 2004, Expert review of anti-infective therapy.

Human T-Cell Retrovirus and Adult T-Cell Lymphoma and Leukemia: Possible Factors on Viral Incidence

M. Wainberg, S. Broder, Yoshiaki Ito, 1983 .

The antimalarial drug amodiaquine possesses anti‐ZIKA virus activities

M. Wainberg, Yingshan Han, T. Mesplède, 2018, Journal of medical virology.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Early immune adaptation in HIV-1 revealed by population-level approaches

Todd M. Allen, H. Jessen, T. Allen, 2014, Retrovirology.

Has the time come to abandon efavirenz for first-line antiretroviral therapy?

M. Wainberg, F. Raffi, A. Pozniak, 2014, The Journal of antimicrobial chemotherapy.

Integrase Strand Transfer Inhibitors in HIV Therapy

M. Wainberg, T. Mesplède, 2013, Infectious Diseases and Therapy.

The R262K Substitution Combined with H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir

M. Wainberg, Said A Hassounah, T. Mesplède, 2014, Antimicrobial Agents and Chemotherapy.

The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus

M. Wainberg, S. Baruchel, 1992, Journal of leukocyte biology.

Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection

M. Wainberg, P. Cahn, R. Bethell, 2007, Antiviral Chemistry & Chemotherapy.

Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection

M. Wainberg, P. Cahn, R. Bethell, 2007, Antiviral chemistry & chemotherapy.

Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis.

M. Wainberg, C. Liang, M. Götte, 2003, Virology.

Analysis of Efficiency and Fidelity of HIV-1 (+)-Strand DNA Synthesis Reveals a Novel Rate-limiting Step during Retroviral Reverse Transcription*

M. Wainberg, M. Götte, M. Kameoka, 2001, The Journal of Biological Chemistry.

Temporal Coordination between Initiation of HIV (+)-Strand DNA Synthesis and Primer Removal*

M. Wainberg, H. Heumann, M. Götte, 1999, The Journal of Biological Chemistry.

Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication

M. Wainberg, E. Arts, J. Mak, 1994, Journal of virology.

Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?

M. Wainberg, P. Coplan, Jorge Martínez, 2006, Antiviral research.

Replication of cytomegalovirus in human thymic epithelial cells

M. Wainberg, B. Spira, K. Numazaki, 2004, Medical Microbiology and Immunology.

Infection of cultured human thymic epithelial cells by human immunodeficiency virus.

M. Wainberg, B. Spira, K. Numazaki, 1989, Clinical immunology and immunopathology.

Replication of measles virus in cultured human thymic epithelial cells

M. Wainberg, K. Numazaki, H. Goldman, 1989, Journal of medical virology.

Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation

M. Wainberg, J. Hiscott, A. Roulston, 1996, Journal of virology.

How will the ebola crisis impact the HIV epidemic?

M. Wainberg, A. Lever, 2014, Retrovirology.

Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef

M. Wainberg, T. Bar-Magen, Andrew T Roland, 2011, Journal of Virology.

Induction of ReIA ( p 65 ) and IicBo Subunit Expression during Differentiation of Human Peripheral Blood Monocytes to Macrophages 1

M. Wainberg, J. Hiscott, M. Papacchini, 2005 .

Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages.

M. Wainberg, J. Hiscott, A. Roulston, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

M. Wainberg, E. Haddad, M. Gill, 2017, Retrovirology.

Translation of Pr55(gag) augments packaging of human immunodeficiency virus type 1 RNA in a cis-acting manner.

M. Wainberg, C. Liang, R. Russell, 2002, AIDS research and human retroviruses.

Clinical correlates of in vitro HIV‐1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial

J. Singer, J. Montaner, M. Wainberg, 1993, AIDS.

Efficient Gap Repair Catalyzed In Vitro by an Intrinsic DNA Polymerase Activity of Human Immunodeficiency Virus Type 1 Integrase

M. Wainberg, A. Acel, E. Faust, 1998, Journal of Virology.

Inhibition of CD4 Translation Mediated by Human Immunodeficiency Virus Type 1 Envelope Protein in a Cell-free System*

M. Wainberg, R. Geleziunas, S. Bour, 1997, The Journal of Biological Chemistry.

Lack of Effect of Recombinant Human Growth Hormone on the In Vitro Activities of Antiretroviral Drugs against Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, E. Daar, 2004, Antimicrobial Agents and Chemotherapy.

Cell surface down‐modulation of CD4 after infection by HIV‐1

M. Wainberg, R. Geleziunas, S. Bour, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs

M. Wainberg, B. Brenner, 2012, Molecular biology international.

Desferrioxamine and HIV

M. Wainberg, S. Baruchel, Qing Gao, 1991, The Lancet.

In Vitro Antiviral Activity and Cross-Resistance Proﬁle of PL-100, a Novel Protease Inhibitor of Human Immunodeﬁciency Virus Type 1 (cid:1)

M. Wainberg, J. Schapiro, N. Parkin, 2007 .

Cyclosporine-induced deterioration in patients with AIDS.

M. Wainberg, S. Walmsley, A. Rachlis, 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Chiamydia trachomaatis infections in infants

M. Wainberg, K. Numazaki, Jane C McDonald, 2005 .

Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors

M. Wainberg, M. Ntemgwa, B. Brenner, 2006, Antimicrobial Agents and Chemotherapy.

Immunological responsiveness against tumors induced by avian sarcoma virus: reduced expression of pp60src kinase activity in regressing tumors

M. Wainberg, L. Poulin, L. Grisé-Miron, 1985, Journal of virology.

Altered pp60src kinase activity in regressing tumors induced by Rous sarcoma virus.

M. Wainberg, B. Spira, L. Poulin, 1987, Cancer letters.

Estimates of the virological benefit of antiretroviral therapy are both assay‐ and analysis‐dependent

J. Montaner, M. Wainberg, D. Cooper, 1998, AIDS.

Impaired Rescue of Chain-Terminated DNA Synthesis Associated with the L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase

M. Wainberg, D. Turner, B. Marchand, 2005, Antimicrobial Agents and Chemotherapy.

Cellular and humoral anti‐tumor immune responsiveness in chickens bearing tumors induced by avian sarcoma virus

M. Wainberg, M. Yu, E. Schwartz-Luft, 1977, International Journal of Cancer.

Different effects of breast cancer, HIV-1 infection and chemotherapy on inducible natural immunity.

M. Wainberg, B. Brenner, C. Vo, 1994, Leukemia.

High levels of IgE in patients suffering from frequent recurrent herpes simplex lesions.

M. Wainberg, J. Portnoy, J. Lagacé-Simard, 1986, Journal of Allergy and Clinical Immunology.

Combination of the R263K and M184I/V Resistance Substitutions against Dolutegravir and Lamivudine Decreases HIV Replicative Capacity

M. Wainberg, T. Mesplède, Diane N. Singhroy, 2015, Antimicrobial Agents and Chemotherapy.

The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity

M. Wainberg, Hong-tao Xu, Y. Quan, 2010, Antimicrobial Agents and Chemotherapy.

Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells

M. Wainberg, J. Hiscott, M. D'Addario, 1992, The Journal of experimental medicine.

HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

M. Wainberg, C. Tremblay, L. Vézina, 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance.

J. Lisziewicz, H. Jessen, F. Lori, 1997, AIDS research and human retroviruses.

Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.

M. Wainberg, H. Salomón, T. Mansour, 1995, Journal of medicinal chemistry.

Early HIV treatment to forestall drug resistance.

M. Wainberg, 2016, The Lancet. Infectious diseases.

Mechanistic Studies of Early Pausing Events during Initiation of HIV-1 Reverse Transcription*

M. Wainberg, L. Rong, L. Kleiman, 1998, The Journal of Biological Chemistry.

The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity

M. Wainberg, L. Rong, L. Kleiman, 1997, Journal of virology.

Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1

M. Wainberg, J. Darlix, L. Kleiman, 1997, Journal of virology.

Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription

M. Wainberg, J. Mak, L. Kleiman, 1996, Journal of virology.

Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.

M. Wainberg, H. Salomón, J. Wright, 1995, Gene.

Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages

M. Wainberg, E. Arts, R. Geleziunas, 1993, Antimicrobial Agents and Chemotherapy.

to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation 2

M. Wainberg, S. Colby-Germinario, Yingshan Han, 2013 .

Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function.

M. Wainberg, Hong-tao Xu, Y. Quan, 2010, The Journal of antimicrobial chemotherapy.

Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

M. Wainberg, B. Brenner, D. Moisi, 2004, Antimicrobial Agents and Chemotherapy.

HIV Resistance to Nevirapine and Other Non‐Nucleoside Reverse Transcriptase Inhibitors

M. Wainberg, 2003, Journal of acquired immune deficiency syndromes.

Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide nonnucleoside compounds.

M. Wainberg, M. Parniak, G. Borkow, 1995, Biochemistry.

The Role of CD4 and its Downmodulation in Establishment and Maintenance of HIV‐1 Infection

M. Wainberg, R. Geleziunas, S. Bour, 1994, Immunological reviews.

A Significant Reduction in the Frequency of HIV-1 Drug Resistance in Québec from 2001 to 2011 Is Associated with a Decrease in the Monitored Viral Load

M. Wainberg, B. Brenner, D. Moisi, 2014, PloS one.

Dynamin-Dependent Endocytosis Cell-to-Cell Transmission via Productive Entry of HIV-1 during

M. Wainberg, D. Donahue, Richard Sloan, 2014 .

Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

M. Wainberg, J. Münch, T. Mesplède, 2013, Journal of Virology.

The Role of Antiretrovirals and Drug Resistance in Vertical Transmission of HIV‐1 Infection

M. Wainberg, B. Brenner, 2000, Annals of the New York Academy of Sciences.

Sensitivity and Resistance to (+)-Calanolide a of Wild-Type and Mutated Forms of HIV-1 Reverse Transcriptase

M. Wainberg, M. Parniak, R. Buckheit, 1998, Antiviral therapy.

Inhibitory effect of 3'-azido-3'-deoxythymidine on proliferative responsiveness of CD8+ lymphocytes to interleukin-2.

M. Wainberg, D. Phaneuf, L. Mercure, 1994, Clinical and diagnostic laboratory immunology.

Design, Anti-Hiv Activity, Cellular Pharmacology and Conformation of BCH-189 [(±)3TC], A Novel Nucleoside Analogue

M. Wainberg, J. Kraus, M. Hershfield, 1992 .

Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells

M. Wainberg, X. Li, F. Boulerice, 1991, Journal of virology.

Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT‐Resistant Variants of HIV‐1

J. Montaner, M. Wainberg, J. Ruedy, 1990, Annals of the New York Academy of Sciences.

Inhibition by AZT of HIV‐1 Replication in Acutely Infected U‐937 Cells

M. Wainberg, F. Boulerice, François Boulerice, 1990, Journal of leukocyte biology.

Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelines.

M. Wainberg, C. Tremblay, A. Rachlis, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Effects of drug resistance on viral load in patients failing antiretroviral therapy

M. Wainberg, J. Routy, Viet-An Nguyen, 2006, Journal of medical virology.

HIV transmission and primary drug resistance.

M. Wainberg, D. Turner, 2006, AIDS reviews.

Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.

M. Wainberg, B. Brenner, M. Gornitsky, 1994, Clinical and diagnostic laboratory immunology.

Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell lines.

M. Wainberg, M. Tremblay, 1989, The Journal of infectious diseases.

Cessation of zidovudine therapy may lead to increased replication of HIV-1.

K. Gelmon, J. Montaner, M. Wainberg, 1989, Journal of the American Medical Association (JAMA).

Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.

M. Wainberg, N. Gilmore, O. Kendall, 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The role of Tat in HIV-1 replication: an activator and/or a suppressor?

M. Wainberg, C. Liang, 2002, AIDS reviews.

Changes in natural immunity during the course of HIV‐1 infection

M. Wainberg, B. Brenner, M. Gornitsky, 1993, Clinical and experimental immunology.

Increased LAK activity against HIV‐infected cell lines in HIV‐1+ individuals

M. Wainberg, Z. Bentwich, B. Brenner, 1992, Clinical and experimental immunology.

Role of Antibody‐Dependent Cellular Cytotoxicity and Lymphokine‐Activated Killer Cells in AIDS and Related Diseases

M. Wainberg, B. Brenner, C. Gryllis, 1991, Journal of leukocyte biology.

AIDS: Where Are We Now?

M. Wainberg, D. Turner, Guest Cme, 2004 .

HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters

M. Wainberg, B. Brenner, J. Routy, 2017, The Journal of antimicrobial chemotherapy.

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination

M. Wainberg, S. Colby-Germinario, Hong-tao Xu, 2011, AIDS.

Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection.

M. Wainberg, Z. Bentwich, A. Kalinkovich, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase

M. Wainberg, M. Parniak, J. Barnard, 1997, Journal of virology.

The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin

M. Wainberg, X. Yao, M. Pollak, 1991, Antimicrobial Agents and Chemotherapy.

Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2011, Virus research.

HIV‐1 associated down‐modulation of CD4 gene expression is differentially restricted in lymphocytic and monocytic cell lines

M. Wainberg, R. Geleziunas, S. Bour, 1994, Journal of Leukocyte Biology.

Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1

M. Wainberg, J. Hiscott, M. D'Addario, 1992, Journal of virology.

Effects of a Single Amino Acid Substitution within thep2 Region of Human Immunodeficiency Virus Type 1 on Packagingof Spliced ViralRNA

M. Wainberg, C. Liang, A. Roldán, 2003, Journal of Virology.

The First Report of HIV-1 Group O Infection in Canada

M. Wainberg, B. Brenner, D. Moisi, 2014 .

Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.

M. Wainberg, R. Geleziunas, S. Bour, 1994, The Journal of general virology.

Effects of Infection by HIV‐1, Cytomegalovirus, and Human Measles Virus on Cultured Human Thymic Epithelial Cells

M. Wainberg, K. Numazaki, H. Goldman, 1989, Microbiology and immunology.

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

M. Wainberg, P. Quashie, Tamar Veres, 2013, Antimicrobial Agents and Chemotherapy.

Preferential lymphocyte-mediated cytotoxicity of syngeneic target cells in chickens bearing tumors induced by avian sarcoma virus.

M. Wainberg, B. Beiss, L. Mirón, 1985, Cancer letters.

Subtype-Speciﬁc Analysis of the K65R Substitution in HIV-1 That Confers Hypersusceptibility to a Novel Nucleotide-Competing Reverse Transcriptase Inhibitor

M. Wainberg, R. Bethell, S. Colby-Germinario, 2015 .

HIV-1 Subtype Variability in Vif Derived from Molecular Clones Affects APOBEC3G-Mediated Host Restriction

M. Wainberg, Maureen Oliveira, Susan M. Schader, 2013, Intervirology.

Phenotypic differences between tumor cells derived from different stages of neoplastic growth.

M. Wainberg, R. Germinario, 1982, European journal of cancer & clinical oncology.

Development of HIV/AIDS Vaccine Using Chimeric gag-env Virus-Like Particles

M. Wainberg, Y. Li, L. Luo, 1999, Biological chemistry.

Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells

M. Wainberg, M. Tremblay, R. Sékaly, 1990, The Journal of experimental medicine.

World AIDS Day: together we will stop HIV transmission and conquer AIDS

M. Wainberg, A. Lever, A. Lever, 2013, Retrovirology.

Packaging of Spliced Viral RNA Immunodeficiency Virus Type 1 on within the p 2 Region of Human Effects of a Single Amino Acid Substitution

M. Wainberg, C. Liang, A. Roldán, 2003 .

Arginine Methylation of the Human Immunodeficiency Virus Type 1 Tat Protein by PRMT6 Negatively Affects Tat Interactions with both Cyclin T1 and the Tat Transactivation Region

S. Richard, M. Wainberg, Cédric F. Invernizzi, 2007, Journal of Virology.

Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase.

M. Wainberg, E. Nagy, M. Parniak, 1996, Protein expression and purification.

Altered constitutive and stress-regulated heat shock protein 27 expression in HIV type 1-infected cell lines.

M. Wainberg, B. Brenner, E. Pearson, 1995, AIDS Research and Human Retroviruses.

Anti-Human Immunodeficiency Virus Type 1 Activity, Intracellular Metabolism, and Pharmacokinetic Evaluation of 2′-Deoxy-3′-Oxa-4′-Thiocytidine

M. Wainberg, H. Gourdeau, N. Nguyen-ba, 1999, Antimicrobial Agents and Chemotherapy.

Development of HIV‐1 resistance to (−)2′‐deoxy‐3′‐thiacytidine in patients with AIDS or advanced AIDS‐related complex

J. Montaner, M. Wainberg, H. Salomón, 1995, AIDS.

Pressure of Zidovudine Accelerates the Reversion of Lamivudine Resistance-Conferring M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Moisi, 2002, Antimicrobial Agents and Chemotherapy.

Mechanisms of virus-induced immune suppression.

M. Wainberg, E. L. Mills, 1985, Canadian Medical Association journal.

Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice

A. Heredia, N. Le, M. Wainberg, 2017, The Journal of antimicrobial chemotherapy.

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration

M. Wainberg, F. Nekka, S. Sanche, 2017, CPT: pharmacometrics & systems pharmacology.

Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference

M. Wainberg, Jian Hui Wu, Long Yang, 2017, Viruses.

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication#

M. Wainberg, S. Colby-Germinario, Nathan Osman, 2017, Scientific Reports.

Expression of the somatostatin gene in human astrocytoma cell lines

M. Wainberg, H. Schipper, G. Tannenbaum, 1996, Clinical and diagnostic laboratory immunology.

Infection of human thymic lymphocytes by HIV-1.

M. Wainberg, M. Tremblay, K. Numazaki, 1990, Journal of acquired immune deficiency syndromes.

The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates

M. Wainberg, B. Brenner, D. Moisi, 2003, Antimicrobial Agents and Chemotherapy.

Resistance Issues With New Nucleoside/Nucleotide Backbone Options

M. Wainberg, D. Turner, 2004, Journal of acquired immune deficiency syndromes.

Resistance profiles of (+)2'-deoxy-3'-oxa-4'-thiocytidine and (-)2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.

M. Wainberg, H. Salomón, N. Richard, 1999, Nucleosides & nucleotides.

Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane.

M. Wainberg, L. L'Heureux, Z. Gu, 1999, Nucleosides & nucleotides.

The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.

M. Wainberg, E. Arts, M. Parniak, 1994, The Journal of biological chemistry.

Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.

M. Wainberg, E. Arts, L. Kleiman, 1994, The Journal of biological chemistry.

COX

M. Wainberg, P. Cahn, R. Bethell, 2020, Catalysis from A to Z.

Chemoprophylaxis of HIV infection: moving forward with caution.

M. Wainberg, R. Grant, 2006, The Journal of infectious diseases.

Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

D. W. Weiss, M. Wainberg, J. Mcclatchy, 1974, Journal of the National Cancer Institute.

Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).

D. W. Weiss, M. Wainberg, P. Minden, 1974, Journal of the National Cancer Institute.

Nature, time course and dose dependence of zidovudine‐related side effects: results from the Multicenter Canadian Azidothymidine Trial

K. Gelmon, J. Montaner, M. Wainberg, 1989, AIDS.

Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes

M. Wainberg, J. Lifson, B. Keele, 2018, Journal of Virology.

Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection

M. Wainberg, D. Church, M. Gill, 2010, Retrovirology.

Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification.

M. Wainberg, F. Plummer, L. D'costa, 1990, The Journal of infectious diseases.

Investigation of the active center of trypsin using photochromic substrates.

M. Wainberg, B. Erlanger, 1971, Biochemistry.

Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris.

M. Wainberg, Xiaojian Yao, M. Parniak, 1992, Virology.

Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries

M. Wainberg, M. Ntemgwa, Susan M. Schader, 2008, Journal of the International AIDS Society.

Logeracemin A, an anti-HIV Daphniphyllum alkaloid dimer with a new carbon skeleton from Daphniphyllum longeracemosum.

M. Wainberg, Yingshan Han, J. Yue, 2014, Journal of the American Chemical Society.

Animal Rights: a Contractarian Defence

M. Wainberg, Mark Rowlands, 1998 .

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2017, BMC Infectious Diseases.

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

David Thompson, Laurence Meyer, Jean-Pierre Aboulker, 2015, The New England journal of medicine.

Mechanism of Action and In Vitro Activity of 1′,3′-Dioxolanylpurine Nucleoside Analogues against Sensitive and Drug-Resistant Human Immunodeficiency Virus Type 1 Variants

M. Wainberg, L. L'Heureux, N. Nguyen-ba, 1999, Antimicrobial Agents and Chemotherapy.

The need for microbicides: why aren't women's groups more involved in the fight against AIDS?

M. Wainberg, 1999, AIDS research and human retroviruses.

Limonoids with Anti-HIV Activity from Cipadessa cinerascens.

M. Wainberg, Yingshan Han, J. Yue, 2015, Journal of natural products.

Strategies for the optimal sequencing of antiretroviral drugs toward overcoming and preventing drug resistance

M. Wainberg, B. Brenner, J. Martínez-Cajas, 2007 .

Development of antiretroviral drug resistance.

M. Wainberg, B. Brenner, G. Zaharatos, 2011, The New England journal of medicine.

Effect of co-incubation with cytomegalovirus on growth of interleukin 2-dependent lymphocytes.

M. Wainberg, K. Numazaki, H. Goldman, 1988, Microbial pathogenesis.

Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1.

M. Wainberg, V. Prasad, L. Rezende, 1997, Nucleic acids research.

Increased fidelity of drug-selected M184V mutated HIV-1 reverse transcriptase as the basis for the effectiveness of 3TC in HIV clinical trials.

M. Wainberg, 1997, Leukemia.

Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase

M. Wainberg, H. Salomón, W. C. Drosopoulos, 1996, Science.

Characterization of Antiviral Activity of Benzamide Derivative AH0109 against HIV-1 Infection

M. Wainberg, G. Kobinger, Guojun Wu, 2013, Antimicrobial Agents and Chemotherapy.

Chlamydia trachomatis infections in infants.

M. Wainberg, J. Mcdonald, K. Numazaki, 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Human Immunodeficiency Virus Type 1-Associated Cd4 Downmodulation

M. Wainberg, R. Geleziunas, S. Bour, 1994, Advances in Virus Research.

Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.

J. Lisziewicz, F. Lori, M. Wainberg, 1998, AIDS.

Virus-mediated abrogation of chicken lymphocyte responsiveness to mitogenic stimulus.

M. Wainberg, B. Beiss, E. Israel, 1980, Avian diseases.

Thymic dependence of cell-mediated immunity to avian sarcomas in chickens. Immunological characterization of a nonvirion antigen in virus-infected cells.

M. Wainberg, R. Wahi, B. Beiss, 1979, Cellular immunology.

Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro.

D. W. Weiss, M. Wainberg, F. Doljanski, 1974, Proceedings of the National Academy of Sciences of the United States of America.

A new class of HIV-1 inhibitors and the target identification via proteomic profiling

M. Wainberg, Bin Zhou, Hu Zhou, 2018, Science China Chemistry.

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

M. Wainberg, R. Geleziunas, S. Bour, 1995 .

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

M A Wainberg, M. Wainberg, R. Geleziunas, 1995, Microbiological reviews.

Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1

M. Wainberg, S. Bour, F. Boulerice, 1991, Journal of virology.

Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor

Hongtao Xu, D. Hazuda, M. Wainberg, 2010, Journal of Virology.

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.

M. Wainberg, H. Salomón, M. Smith, 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

M A Wainberg, M. Wainberg, H. Salomón, 1994, Antimicrobial Agents and Chemotherapy.

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

M. Wainberg, C. Boucher, P. Schipper, 1993, Antimicrobial Agents and Chemotherapy.

Differential susceptibility of avian sarcoma cells derived from different periods of tumor growth to natural killer cell activity.

M. Wainberg, B. Beiss, S. Beaupré, 1983, Cancer research.

Expression of avian sarcoma virus genes in tumor cells derived from different periods of tumor growth.

M. Wainberg, L. Poulin, 1987, Microbial pathogenesis.

Avian Sarcomas: Immune Responsiveness and Pathology

M. Wainberg, M. Halpern, 1986 .

Alteration of phenotype of 'regressor' avian sarcoma cells following treatment with phorbol ester.

M. Wainberg, L. Poulin, 1983, Cancer letters.

Involvement of Macrophage-like Cellsin Growthof TumorsInducedby AvianSarcomaVirus1

M. Wainberg, B. Beiss, H. Fong, 1983 .

Immune stimulation of sensitized chicken lymphocytes by avian retrovirus proteins.

M. Wainberg, E. Israel, E. Israèl, 1982, The Journal of general virology.

Effects of dexamethasone on antigen expression and virus production in avian sarcoma virus-transformed cells.

M. Wainberg, L. Silber, S. Cohen, 1982, Journal of cell science.

Immune selection of tumor cell variants in chickens bearing tumors induced by avian sarcoma virus.

M. Wainberg, M. Yu, E. Israel, 1982, Cancer research.

Studies on interactions between plasminogen activator-containing fluids and avain and murine lymphocytes.

M. Wainberg, S. Cohen, 1981, Developmental and comparative immunology.

Decreased production of transforming virus and altered antigenic behaviour in cultured avian sarcoma cells.

M. Wainberg, M. Yu, E. Israel, 1979, The Journal of general virology.

Development of cellular anti-tumor immunity in chickens bearing tumors induced by Rous sarcoma virus.

M. Wainberg, E. Israël, 1977, Journal of immunology.

Reactivity of serum from rous‐sarcoma‐bearing chickens with autochthonous and with allogeneic tumor cells: Preferential autochthonous recognition

D. W. Weiss, M. Wainberg, F. Doljanski, 1975, International journal of cancer.

Neutralization of pseudotypes of vesicular stomatitis virus by sera from avian retrovirus‐infected hosts

M. Wainberg, R. Mandeville, P. Rohan, 1979, International journal of cancer.

RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I

M. Wainberg, J. Hiscott, J. Lacoste, 2010, Journal of Virology.

Differential expression of relevant Rous sarcoma-associated antigens in cultured cells.

M. Wainberg, M. Yu, E. Schwartz-Luft, 1977, Cancer research.

Review: immunologic response to protease inhibitor-based highly active antiretroviral therapy: a review.

M. Wainberg, B. Clotet, 2007, AIDS patient care and STDs.

Non-specific effects of avian retrovirus co-incubation on lymphocyte function: abrogation of antigen- and mitogen-induced proliferative responsiveness.

M. Wainberg, M. Yu, E. Israel, 1979, Immunology.

Infection-Mediated Resistance to Cell Fusion by Inactive Sendai Virus 1

M. Wainberg, C. Howe, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

New cd4( +) cell line susceptible to infection by hiv‐1

M. Wainberg, M. Tremblay, R. Geleziunas, 1989, Journal of medical virology.

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.

M. Wainberg, B. Spira, R. Margolese, 1985, Immunology.

Viral inhibition of lymphocyte mitogenesis: interference with the synthesis of functionally active T cell growth factor (TCGF) activity and reversal of inhibition by the addition of same.

M. Wainberg, R. Margolese, S. Vydelingum, 1983, Journal of immunology.

HIV drug resistance against strand transfer integrase inhibitors

M. Wainberg, T. Mesplède, Kaitlin Anstett, 2017, Retrovirology.

HIV Drug Resistance and the Advent of Integrase Inhibitors

M. Wainberg, P. Quashie, T. Mesplède, 2013, Current Infectious Disease Reports.

Novel therapeutic strategies targeting HIV integrase

M. Wainberg, P. Quashie, Richard Sloan, 2012, BMC Medicine.

Quantitative assessment of the effect of cyproheptadine on spastic paretic gait: a preliminary study

H. Barbeau, S. Gauthier, M. Wainberg, 1986, Journal of Neurology.

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics

David P Wilson, M. Wainberg, S. Blower, 2008, Proceedings of the National Academy of Sciences.

Effect of glucosamine on virus production and antigen expression in avian sarcoma virus-transformed cells.

M. Wainberg, R. Mandeville, E. Israèl, 1978, Canadian journal of microbiology.

The role of unintegrated DNA in HIV infection

M. Wainberg, Richard Sloan, 2011, Retrovirology.

Antibody-mediated fusion of FL amnion cells infected with parainfluenza virus type 2.

M. Wainberg, C. Howe, 1972, Immunological communications.

Factors Affecting Cell Fusion Induced by Sendai Virus

M. Wainberg, C. Howe, 1973, Journal of virology.

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

M. Wainberg, E. Arts, 1996, Antimicrobial agents and chemotherapy.

K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine

M. Wainberg, A. Foli, H. Salomón, 1995, Antimicrobial Agents and Chemotherapy.

In vitro Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

M. Wainberg, H. Salomón, J. Cherrington, 1998, Antiviral therapy.

M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA

M. Wainberg, B. Brenner, T. Mesplède, 2017, The Journal of antimicrobial chemotherapy.

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors: A Clinical Review of Antiretroviral Resistance

Joel E Gallant, R. Haubrich, D. Richman, 2002, Antiviral therapy.

Endogenous reverse transcriptase assays reveal synergy between combinations of the M184V and other drug resistance-conferring mutations in interactions with nucleoside analog triphosphates.

M. Wainberg, C. Liang, M. Parniak, 1998, Journal of molecular biology.

Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.

M. Wainberg, E. Arts, M. Parniak, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

M. Wainberg, Q. Gao, C. Boucher, 1993, Antimicrobial Agents and Chemotherapy.

Hydroxyurea in the Treatment of HIV Infection

J. Lisziewicz, F. Lori, M. Wainberg, 2003, Drug safety.

In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

M. Wainberg, A. Foli, B. Anderson, 1996, Antiviral research.

Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues

M. Wainberg, H. Salomón, J. Gillard, 1995 .

The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses

M. Wainberg, C. Liang, M. Götte, 2002, AIDS.

Subtype-Specific Analysis of the K65R Substitution in HIV-1 That Confers Hypersusceptibility to a Novel Nucleotide-Competing Reverse Transcriptase Inhibitor

M. Wainberg, R. Bethell, S. Colby-Germinario, 2015, Antimicrobial Agents and Chemotherapy.

Effects of the W153L Substitution in HIV Reverse Transcriptase on Viral Replication and Drug Resistance to Multiple Categories of Reverse Transcriptase Inhibitors

M. Wainberg, R. Bethell, S. Colby-Germinario, 2014, Antimicrobial Agents and Chemotherapy.

The Connection Domain Mutation N348I in HIV-1 Reverse Transcriptase Enhances Resistance to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation by Diminishing Viral Replication Capacity

M. Wainberg, S. Colby-Germinario, Yingshan Han, 2013, Journal of Virology.

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

M. Wainberg, S. Sarafianos, S. Colby-Germinario, 2013, Antimicrobial Agents and Chemotherapy.

Molecular Mechanism of Antagonism between the Y181C and E138K Mutations in HIV-1 Reverse Transcriptase

Matthew McCallum, M. Wainberg, M. McCallum, 2012, Journal of Virology.

Subunit-Selective Mutational Analysis and Tissue Culture Evaluations of the Interactions of the E138K and M184I Mutations in HIV-1 Reverse Transcriptase

M. Wainberg, B. Brenner, M. McCallum, 2012, Journal of Virology.

Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C

M. Wainberg, Hong-tao Xu, Y. Quan, 2010, Retrovirology.

HIV-1 recombinant reverse transcriptase enzymes containing the G 190 A and Y 181 C resistance mutations remain sensitive to etravirine

M. Wainberg, B. Brenner, Hong-tao Xu, 2009 .

Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance

M. Wainberg, M. Ntemgwa, B. Brenner, 2009, Retrovirology.

Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C.

M. Wainberg, B. Brenner, T. Kurimura, 2003, AIDS research and human retroviruses.

Enhanced impairment of chain elongation by inhibitors of HIV reverse transcriptase in cell-free reactions yielding longer DNA products.

M. Wainberg, C. Liang, Y. Quan, 1998, Nucleic acids research.

Dominance of the E89G Substitution in HIV-1 Reverse Transcriptase in Regard to Increased Polymerase Processivity and Patterns of Pausing*

M. Wainberg, L. Rong, C. Liang, 1998, The Journal of Biological Chemistry.

Perspectives on antiviral drug development.

M. Wainberg, 2009, Antiviral research.

Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes

M. Wainberg, C. Tsoukas, D. Phaneuf, 1994, Antimicrobial Agents and Chemotherapy.

Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine

M A Wainberg, M. Wainberg, Q. Gao, 1992, Journal of virology.

Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1.

M. Wainberg, S. Wise, L. Kleiman, 2000, Journal of molecular biology.

HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction.

M A Wainberg, M. Wainberg, X. Li, 1999, Archives of biochemistry and biophysics.

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.

M. Wainberg, E. Arts, E. J. Arts, 1996, Advances in virus research.

DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity.

M. Wainberg, E. Arts, J. Mak, 1994, The Journal of general virology.

Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors

M. Wainberg, B. Brenner, D. Moisi, 2011, Journal of medical virology.

Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT.

M. Wainberg, H. Salomón, C. Tsoukas, 1999, Nucleosides & nucleotides.

Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection

J. Montaner, M. Wainberg, D. Kuritzkes, 2005, Antiviral therapy.

In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

M. Wainberg, D. Moisi, S. Colby-Germinario, 2011, Antimicrobial Agents and Chemotherapy.

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir

M. Wainberg, 2013, HIV/AIDS.

Genotypic Assays for Monitoring Drug Resistance in HIV-1 Infection and for Other Chronic Viral Diseases

M. Wainberg, Yingshan Han, 2017 .

The Use of Genotypic Assays for Monitoring the Development of Resistance to Antiviral Therapy for HIV-1 Infection and Other Chronic Viral Diseases

M. Wainberg, J. Martínez-Cajas, M. Petrella, 2009 .

Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine.

M. Wainberg, P. Cahn, 2010, The Journal of antimicrobial chemotherapy.

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors

M. Wainberg, C. Tremblay, Eugene L. Asahchop, 2012, Antimicrobial Agents and Chemotherapy.

Might the M184V substitution in HIV-1 RT confer clinical benefit?

M. Wainberg, M. Petrella, 2002, AIDS Reviews.

The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA

M. Wainberg, L. Rong, L. Kleiman, 1997, Journal of virology.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

J. Montaner, M. Wainberg, D. Cooper, 1998, JAMA.

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

S. Hammer, J. Nachega, M. Wainberg, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Time to act: global apathy towards HIV/AIDS is a crime against humanity

R. Hogg, J. Montaner, M. Wainberg, 2002, The Lancet.

Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulation.

M. Wainberg, C. Liang, T. Bar-Magen, 2010, AIDS.

Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA

M. Wainberg, E. Arts, S. L. Le Grice, 1996, Journal of virology.

Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus

M. Wainberg, B. Brenner, R. Lalonde, 2003, AIDS.

Public health implications of antiretroviral therapy and HIV drug resistance.

M. Wainberg, G. Friedland, Gerald Friedland, 1998, JAMA.

Analysis of Primer Extension and the First Template Switch during Human Immunodeficiency Virus Reverse Transcription.

M. Wainberg, E. Arts, Z. Li, 1995, Journal of biomedical science.

Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1

M. Wainberg, J. Mak, L. Kleiman, 1994, Journal of virology.

Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles

M. Wainberg, J. Mak, L. Kleiman, 1994, Journal of virology.

Diminished Representation of HIV-1 Variants Containing Select Drug Resistance-Conferring Mutations in Primary HIV-1 Infection

M. Wainberg, B. Brenner, D. Moisi, 2004, Journal of acquired immune deficiency syndromes.

Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients.

M. Wainberg, B. Brenner, J. Routy, 2004, The new microbiologica.

Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.

M. Wainberg, B. Brenner, D. Turner, 2003, The Journal of antimicrobial chemotherapy.

Multiple Effects of the M184V Resistance Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Turner, 2003, Clinical Diagnostic Laboratory Immunology.

Current Insights into Reverse Transcriptase Inhibitor-Associated Resistance

M. Wainberg, A. White, 2000, Antiviral therapy.

Strategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.

M. Wainberg, R. Margolese, 1992, Cancer investigation.

Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues.

M. Wainberg, H. Salomón, J. Gillard, 2010 .

Diminished RNA Primer Usage Associated with the L74V and M184V Mutations in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Provides a Possible Mechanism for Diminished Viral Replication Capacity

M. Wainberg, B. Marchand, M. Götte, 2003, Journal of Virology.

Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase.

M. Wainberg, M. Götte, 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

M. Wainberg, S. Manicklal, Ravindra K. Gupta, 2013, Retrovirology.

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review

M. Wainberg, Said A Hassounah, T. Mesplède, 2016, Pathogens & immunity.

Antiretroviral Therapy

M. Wainberg, Mark A. Wainberg, Jorge L. Martinez-Cajas, 2008, Drugs.

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

M. Wainberg, M. Ntemgwa, B. Brenner, 2006 .

Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells.

M. Wainberg, J. Hiscott, M. D'Addario, 1990, Virology.

Natural Killer Cell Function in Patients With Acquired Immunodeficiency Syndrome and Related Diseases

M. Wainberg, B. Brenner, A. Dascal, 1989, Journal of leukocyte biology.

Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations

M. Wainberg, Maureen Oliveira, Cédric F. Invernizzi, 2007, AIDS.

Molecular Impact of the M184V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase

M. Wainberg, M. Götte, K. Diallo, 2003, Antimicrobial Agents and Chemotherapy.

Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

M. Wainberg, M. Götte, X. Wei, 2000, Nucleic acids research.

The M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Impairs Rescue of Chain-Terminated DNA Synthesis

M. Wainberg, M. Parniak, M. Götte, 2000, Journal of Virology.

25 years of HIV-1 research – progress and perspectives

Kuan-Teh Jeang, M. Wainberg, K. Jeang, 2008, BMC medicine.

Stavudine Resistance: An Update on Susceptibility following Prolonged Therapy

V. Calvez, M. Wainberg, V. Soriano, 1999, Antiviral therapy.

Active replication of human immunodeficiency virus type 1 by peripheral blood mononuclear cells following coincubation with herpes viruses

M. Wainberg, M. Gornitsky, M. Tremblay, 1989, Journal of medical virology.

Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC‐resistant HIV‐1 reverse transcriptase

Michael A. Parniak, Gadi Borkow, M. Wainberg, 1996, AIDS.

Virtues of being faithful: can we limit the genetic variation in human immunodeficiency virus?

M. Wainberg, W. C. Drosopoulos, V. Prasad, 1998, Journal of Molecular Medicine.

Generation and characterization of murine monoclonal antibodies reactive against N‐terminal and other regions of HIV‐1 reverse transcriptase

M. Wainberg, Xuguang Li, M. Parniak, 1993, Journal of medical virology.

Protease inhibitor resistance in HIV-infected patients: molecular and clinical perspectives.

M. Wainberg, Mark A Wainberg, Jorge L Martinez-Cajas, 2007, Antiviral research.

Suppression of plasma viral load below 20 copies/ml is required to achieve a long‐term response to therapy

Julio S. G. Montaner, M. Wainberg, P. Reiss, 1998, AIDS.

Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1

M. Wainberg, R. Chandok, L. Kleiman, 1997, Journal of virology.

Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site

M. Wainberg, B. Roques, E. Arts, 1996, Journal of virology.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

M. Wainberg, S. Gaseitsiwe, I. Kasvosve, 2018, AIDS research and human retroviruses.

The effect of zidovudine on platelet count in HIV-infected individuals.

K. Gelmon, M. Wainberg, J. Ruedy, 1990, Journal of acquired immune deficiency syndromes.

Biochemical Mechanism of HIV-1 Resistance to Rilpivirine*

M. Wainberg, S. Sarafianos, M. Parniak, 2012, The Journal of Biological Chemistry.

Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription

M. Wainberg, E. Arts, 1994, Antimicrobial Agents and Chemotherapy.

Clinical Significance and Biological Basis of HIV Drug Resistance

M. Wainberg, J. Martínez-Cajas, M. Petrella, 2008 .

Biological Basis and Clinical Significance of HIV Resistance to Antiviral Drugs

M. Wainberg, Susan M. Schader, 2008 .

HIV-1 Drug Resistance

M. Wainberg, B. Brenner, 2002 .

HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries.

M. Wainberg, B. Brenner, H. Loemba, 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

HIV Resistance to Antagonists of Viral Reverse Transcriptase

M. Wainberg, 1999 .

Attenuated infectivity of HIV type 1 from epithelial cells pretreated with a tight-binding nonnucleoside reverse transcriptase inhibitor.

M. Wainberg, H. Salomón, M. Parniak, 2002, AIDS research and human retroviruses.

Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with “Hyperattenuated” SIV Constructs

M. Wainberg, M. Luscher, K. MacDonald, 2009, Journal of Virology.

The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition

M. Wainberg, J. Turgeon, D. Flockhart, 2012, Pharmacological Reviews.

Detection of unintegrated human immunodeficiency virus type 1 DNA in persistently infected CD8+ cells.

M. Wainberg, D. Phaneuf, L. Mercure, 1993, The Journal of general virology.

High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells

M. Wainberg, R. Geleziunas, S. Bour, 1990, Journal of virology.

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

M. Wainberg, M. Ntemgwa, B. Brenner, 2009, Antimicrobial Agents and Chemotherapy.

Insights into HIV-1 pathogenesis through drug discovery: 30 years of basic research and concerns for the future

M. Wainberg, Susan M. Schader, 2011 .

Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data

Art F Y Poon, Bluma Brenner, David J H F Knapp, 2011, AIDS.

Impact of Human Immunodeficiency Virus Type 1 RNA Dimerization on Viral Infectivity and of Stem-Loop B on RNA Dimerization and Reverse Transcription and Dissociation of Dimerization from Packaging

M. Wainberg, C. Liang, M. Laughrea, 2000, Journal of Virology.

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors

M. Wainberg, J. Hiscott, A. Roulston, 1995 .

Regulation of Human Immunodeficiency Virus Type 1 and Cytokine Gene Expression in Myeloid Cells by Nf-␬b/rel Transcription Factors

M A Wainberg, M. Wainberg, J. Hiscott, 2022 .

Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression

Chen Liang, S. Richard, M. Wainberg, 2005, Journal of Virology.

NF-κB Protects HIV-1-Infected Myeloid Cells from Apoptosis

M. Wainberg, H. Kwon, J. Hiscott, 1998 .

CRISPR/Cas9: a double-edged sword when used to combat HIV infection

A. Das, B. Berkhout, M. Wainberg, 2016, Retrovirology.

HIV-1 drug resistance: can we overcome?

M. Wainberg, B. Brenner, D. Turner, 2002, Expert opinion on biological therapy.

Gene expression profiling of the host response to HIV-1 B, C, or A/E infection in monocyte-derived dendritic cells.

M. Wainberg, J. Hiscott, P. Wilkinson, 2006, Virology.

Multidrug-Resistant Recombinant Viruses Which Can Lead to the Emergence of Superinfection in a Tat-Dependent Manner, Latent HIV-1 Can Be Reactivated by Cellular

M. Wainberg, D. Donahue, Richard Sloan, 2014 .

Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?

M. Wainberg, C. Liang, R. Russell, 2004, Retrovirology.

NF-κB activation and HIV-1 induced apoptosis

M. Wainberg, H. Kwon, J. Hiscott, 1999 .

Survey NF-kB activation and HIV-1 induced apoptosis

M. Wainberg, H. Kwon, J. Hiscott, 1999 .

Investigational HIV integrase inhibitors in phase I and phase II clinical trials

M. Wainberg, Yingshan Han, T. Mesplède, 2017, Expert opinion on investigational drugs.

The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir

M. Wainberg, B. Brenner, T. Mesplède, 2015, AIDS (London).

The development of novel HIV integrase inhibitors and the problem of drug resistance.

M. Wainberg, P. Quashie, T. Mesplède, 2012, Current opinion in virology.

Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.

M. Wainberg, D. Kuritzkes, D. Pillay, 2017, The Journal of infectious diseases.

Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex.

M. Wainberg, C. Ehresmann, B. Roques, 2002, RNA.

Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins

M. Wainberg, A. Burny, C. Van Lint, 2005, Journal of Virology.

Evolution of HIV integrase resistance mutations

M. Wainberg, P. Quashie, T. Mesplède, 2012, Current opinion in infectious diseases.

Dolutegravir maintains a durable effect against HIV replication in tissue culture even after drug washout.

M. Wainberg, P. Quashie, Nathan Osman, 2015, The Journal of antimicrobial chemotherapy.

Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1

M. Wainberg, B. Brenner, A. Alikhani, 2017, Antimicrobial Agents and Chemotherapy.

Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance.

M. Wainberg, B. Brenner, 2017, Virus research.

The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir

M. Wainberg, B. Brenner, H. Pham, 2016, AIDS.

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors.

M. Wainberg, B. Brenner, E. Martinez, 2016, The Journal of antimicrobial chemotherapy.

Dolutegravir inhibits HIV-1 Env evolution in primary human cells

M. Wainberg, B. Brenner, T. Mesplède, 2015, AIDS.

Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions

M. Wainberg, T. Mesplède, Maureen Oliveira, 2015, Journal of Virology.

Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity.

M. Wainberg, P. Quashie, Nathan Osman, 2014, The Journal of antimicrobial chemotherapy.

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?

M. Wainberg, T. Mesplède, 2014, Viruses.

Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors

M. Wainberg, P. Quashie, T. Mesplède, 2014, AIDS.

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness

M. Wainberg, P. Quashie, Nathan Osman, 2014, Retrovirology.

What if HIV were unable to develop resistance against a new therapeutic agent?

M. Wainberg, F. Raffi, T. Mesplède, 2013, BMC Medicine.

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure

M. Wainberg, C. Petropoulos, Wei Huang, 2013, Retrovirology.

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir

M. Wainberg, T. Fujiwara, P. Quashie, 2011, Journal of Virology.

Pathogenesis and therapy of HIV-1 infection of the central nervous system.

M. Wainberg, R. Geleziunas, H. Schipper, 1992, AIDS.

Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.

M A Wainberg, M. Wainberg, J. Hiscott, 1993, Virology.

Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.

M. Wainberg, L. Rong, M. Kotler, 1998, Journal of molecular biology.

Journal of the International AIDS Society: an important step forward

M. Wainberg, E. Katabira, Shirin Heidari, 2008, Journal of the International AIDS Society.

An Intact U5-Leader Stem Is Important for Efficient Replication of Simian Immunodeficiency Virus

M. Wainberg, C. Liang, J. Whitney, 2001, Journal of Virology.

Novel, Live Attenuated Simian Immunodeficiency Virus Constructs Containing Major Deletions in Leader RNA Sequences

M. Wainberg, C. Liang, J. Whitney, 2001, Journal of Virology.

Leader Sequences Downstream of the Primer Binding Site Are Important for Efficient Replication of Simian Immunodeficiency Virus

M. Wainberg, J. Whitney, K. Diallo, 2000, Journal of Virology.

Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIVmac239

M. Wainberg, J. Whitney, 2006, Retrovirology.

Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells

M. Wainberg, J. Hiscott, M. D'Addario, 1990, Journal of virology.

Selection of TAR RNA-Binding Chameleon Peptides by Using a Retroviral Replication System

M. Wainberg, A. Frankel, V. Calabro, 2004, Journal of Virology.

Replication of Human Immunodeficiency Viruses Engineered with Heterologous Tat-Transactivation Response Element Interactions

M. Wainberg, A. Frankel, Baode Xie, 2003, Journal of Virology.

ReplicationInitiation Site Can Restore Viral That Are Distal from Deletion Mutations in the Immunodeficiency Virus Type 1 Gag Region Compensatory Point Mutations in the Human

M. Wainberg, L. Rong, L. Kleiman, 2014 .

Compensatory Point Mutations in the Human Immunodeficiency Virus Type 1 Gag Region That Are Distal from Deletion Mutations in the Dimerization Initiation Site Can Restore Viral Replication

M. Wainberg, L. Rong, L. Kleiman, 1998, Journal of Virology.

Spliced human immunodeficiency virus type 1 RNA is reverse transcribed into cDNA within infected cells.

M. Wainberg, C. Liang, M. Kameoka, 2004, AIDS research and human retroviruses.

Deletion of stem-loop 3 is compensated by second-site mutations within the Gag protein of human immunodeficiency virus type 1.

M. Wainberg, L. Rong, C. Liang, 2003, Virology.

Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences.

M. Wainberg, C. Liang, M. Laughrea, 2002, Virology.

Hydrophobic Amino Acids in the Human Immunodeficiency Virus Type 1 p2 and Nucleocapsid Proteins Can Contribute to the Rescue of Deleted Viral RNA Packaging Signals

M. Wainberg, L. Rong, L. Kleiman, 2001, Journal of Virology.

Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin.

M. Wainberg, J. Darlix, L. Kleiman, 2001, Virology.

Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins

Nathalie, M. Wainberg, A. Burny, 2005, Journal of Virology.

Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences.

M. Wainberg, B. Roques, Xiaofeng Guo, 2003, Virology.

Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.

M. Wainberg, J. Hiscott, A. Gatignol, 2002, Virology.

The Tat Protein of Human Immunodeficiency Virus Type 1 (HIV-1) Can Promote Placement of tRNA Primer onto Viral RNA and Suppress Later DNA Polymerization in HIV-1 Reverse Transcription

M. Wainberg, Xiaofeng Guo, L. Rong, 2002, Journal of Virology.

Role for Human Immunodeficiency Virus Type 1 Tat Protein in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication

M. Wainberg, L. Rong, C. Liang, 2001, Journal of Virology.

Inhibition of Human Immunodeficiency Virus Type-1 (HIV-1) Replication by Immunor (Im28), a New Analog of Dehydroepiandrosterone

M. Wainberg, Maureen Oliveira, H. Loemba, 2000, Nucleosides, nucleotides & nucleic acids.

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors

M. Wainberg, J. Hiscott, A. Roulston, 1995, Microbiological reviews.

Presence of insulin binding sites on viral particles.

M. Wainberg, R. Germinario, V. Samnotra, 1988, Antiviral research.

Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.

J. Nachega, M. Wainberg, F. Brun-Vézinet, 2013, The Journal of infectious diseases.

Will LEDGIN molecules be able to play a role in a cure for HIV infection?

M. Wainberg, T. Mesplède, 2016, EBioMedicine.

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance.

Dan Turner, M. Wainberg, B. Brenner, 2003, The Journal of antimicrobial chemotherapy.

Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996–2008)

M. Wainberg, N. Pai, M. Klein, 2009, Journal of the International AIDS Society.

Viral abrogation of lymphocyte mitogenesis: induction of a soluble factor inhibitory to cellular proliferation.

M. Wainberg, B. Beiss, E. Israèl, 1980, Immunology.

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration

Jing Leng, M. Wainberg, H. Pham, 2017, mBio.

Infection of human monocytes/macrophages by HIV-1: effect on secretion of IL-1 activity.

M. Wainberg, S. Roy, L. Poulin, 1988, Immunology.

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

M. Wainberg, B. Brenner, 2010, Viruses.

Evolutionary mechanisms of retroviral persistence.

M. Wainberg, J. Whitney, So-Yon Lim, 2011, AIDS reviews.

Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report

M. Wainberg, B. Brenner, A. Dascal, 2008, Retrovirology.

Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study

M. Wainberg, J. Routy, H. Fleury, 2014, PLoS ONE.

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

P. Harrigan, M. Wainberg, B. Brenner, 2013, Antimicrobial Agents and Chemotherapy.

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Bluma G. Brenner, M. Wainberg, B. Brenner, 2002, Journal of Virology.

The effect of mutations in the HIV-1 nucleocapsid protein on strand transfer in cell-free reverse transcription reactions.

M. Wainberg, B. Roques, L. Rong, 2000, Nucleic acids research.

The K65R Mutation Confers Increased DNA Polymerase Processivity to HIV-1 Reverse Transcriptase*

M. Wainberg, M. Parniak, G. Borkow, 1996, The Journal of Biological Chemistry.

High rates of forward transmission events after acute/early HIV-1 infection.

Michel Roger, M. Wainberg, C. Tremblay, 2007, The Journal of infectious diseases.

Infection of human thymic epithelial cells by human cytomegalovirus and other viruses: effect on secretion of interleukin 1-like activity.

M. Wainberg, K. Numazaki, H. Goldman, 1988, Clinical and experimental immunology.

Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines

M. Wainberg, Yingshan Han, Victor G. Kramer, 2014, Virology Journal.

Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

M. Wainberg, C. Tremblay, R. Center, 2013, AIDS research and human retroviruses.

Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera.

M. Wainberg, M. Tremblay, 1990, The Journal of infectious diseases.

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection

M. Wainberg, B. Brenner, D. Moisi, 2004, AIDS.

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

M A Wainberg, M. Wainberg, B. Brenner, 2000, AIDS.

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

M. Wainberg, J. Schapiro, B. Brenner, 2003, AIDS.

Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV.

M. Wainberg, Hong-tao Xu, Y. Quan, 2014, The Journal of antimicrobial chemotherapy.

Role of the Mononuclear Phagocyte System in the Development of Acquired Immunodeficiency Syndrome (AIDS)

M. Wainberg, Sophie Roy, 1988, Journal of leukocyte biology.

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

T. F. Rinke de Wit, D. Katzenstein, R. Shafer, 2015, PloS one.

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses

M. Wainberg, H. Pham, T. Mesplède, 2016, Retrovirology.

The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance

M. Wainberg, T. Mesplède, Maureen Oliveira, 2015, Journal of Virology.

Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.

M. Wainberg, S. Friedman, E. Drucker, 1998, AIDS (London).

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline

M. Wainberg, C. Tremblay, B. Brenner, 2013, AIDS.

Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: Landmark HIV-1 research honoured

B. Berkhout, M. Wainberg, P. Borrow, 2013, Retrovirology.

Inhibitors of the Human Immunodeficiency Virus Protease

M. Wainberg, J. Martínez-Cajas, 2009 .

An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHIEV2E Quality Control Study

G. Gottlieb, M. Wainberg, F. Brun-Vézinet, 2011, Journal of Clinical Microbiology.

Might dolutegravir be part of a functional cure for HIV?

M. Wainberg, Yingshan Han, T. Mesplède, 2016, Canadian journal of microbiology.

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

M. Wainberg, E. Haddad, M. Gill, 2017, Retrovirology.

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy

M. Wainberg, T. Mesplède, 2015, Journal of the International AIDS Society.

PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA

S. Richard, M. Wainberg, Stéphane Richard, 2006, Retrovirology.

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

P. Harrigan, B. Yip, R. Hogg, 2016, BMC Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.

M. Wainberg, J. Hiscott, L. Kleiman, 1997, Journal of molecular biology.

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

M. Wainberg, Q. Gao, M. Parniak, 1992, Journal of virology.

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

M. Wainberg, B. Brenner, C. Boucher, 2018, The Journal of infectious diseases.

Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout

M. Wainberg, B. Brenner, Nathan Osman, 2018, AIDS.

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses

M. Wainberg, H. Pham, T. Mesplède, 2016, Retrovirology.

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

M. Wainberg, P. Quashie, Tamar Veres, 2014, Antimicrobial Agents and Chemotherapy.

A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.

M. Wainberg, P. Quashie, Yingshan Han, 2012, Journal of virological methods.

Reconsidering the lifetime deferral of blood donation by men who have sex with men

M. Wainberg, N. Gilmore, Talia Shuldiner, 2010, Canadian Medical Association Journal.

Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity

M. Wainberg, M. Parsons, J. Bruneau, 2015, AIDS.

Susceptibility of EBV-carrying B cell lines to infection by HIV-1: variability of production of progeny virus and expression of viral antigens.

M. Wainberg, M. Tremblay, 1989, Cancer letters.

Heat Shock Protein-based Therapeutic Strategies against Human Immunodeficiency Virus Type Infection Stress Proteins in Hii? Infection Heat Shock Proteins Function as Intracellular Molecular Chaperones Hsps Play Central Roles in Immune Response

M. Wainberg, B. Brenner, 2022 .

The Influence of Protease Inhibitor Resistance Profiles on Selection of HIV Therapy in Treatment-Naive Patients

M. Wainberg, J. Schapiro, B. Brenner, 2003, Antiviral therapy.

AVT 8(6) in progress

R. Haubrich, D. Richman, M. Wainberg, 2003 .

Isolation of drug‐resistant variants of HIV‐1 from patients on long‐term zidovudine therapy

K. Gelmon, J. Montaner, M. Wainberg, 1989, AIDS.

Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency.

O. Djurdjev, M. Wainberg, J. Freedman, 1998, AIDS research and human retroviruses.

Achieving the 90-90-90 target: incentives for HIV testing.

J. Montaner, M. Wainberg, M. Hull, 2016, The Lancet. Infectious diseases.

CRISPR / Cas 9-Derived Mu tations Both Inhibit HIV-1 Replication and Accelerate Viral Escape Graphical

P. Gendron, M. Wainberg, Fei Guo, 2016 .

Early immune adaptation in HIV-1 revealed by population-level approaches

Todd M. Allen, H. Jessen, M. Carrington, 2014, Retrovirology.

Differential effects of chemotherapy-induced and HIV-1-induced immunocompromise on NK and LAK activities using breast cancer and HIV-1 seropositive patient populations.

M. Wainberg, B. Brenner, M. Gornitsky, 1991, Anticancer research.

OPINION Evolution of HIV integrase resistance mutations

M. Wainberg, P. Quashie, T. Mesplède, 2012 .

Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239

M. Wainberg, B. Brenner, D. Moisi, 2015, Journal of Virology.

Simian-Tropic HIV as a Model To Study Drug Resistance against Integrase Inhibitors

M. Wainberg, Said A Hassounah, T. Mesplède, 2015, Antimicrobial Agents and Chemotherapy.

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

M. Wainberg, D. Moisi, Maureen Oliveira, 2010, Antimicrobial Agents and Chemotherapy.

JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1

M. Wainberg, Yingshan Han, T. Mesplède, 2017, Journal of Virology.

HIV‐specific cytotoxic T‐lymphocyte activity in immunologically normal HIV‐infected persons

M. Wainberg, C. Tsoukas, N. Bernard, 1998, AIDS.

Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.

M. Wainberg, M. Tremblay, J. Hiscott, 1990, Journal of immunology.

Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1

M. Wainberg, B. Brenner, X. X. Peng, 1996, Clinical and diagnostic laboratory immunology.

Direct involvement of extracellular HIV-1 virions in the apoptosis of CD8+ lymphocytes: a two-step model.

M. Wainberg, L. Mercure, 1994, Medical hypotheses.

The Role of Surrogate Markers in the Clinical Development of Antiretroviral Therapy: A Model for Early Evaluation of Targeted Cancer Drugs

J. Montaner, M. Wainberg, G. Batist, 2004, Cancer investigation.

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA

M. Wainberg, C. Liang, Wei-jun Zhu, 2015, Retrovirology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Inducible Expression of IκBα Repressor Mutants Interferes with NF-κB Activity and HIV-1 Replication in Jurkat T Cells*

M. Wainberg, H. Kwon, J. Hiscott, 1998, The Journal of Biological Chemistry.

The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency

M. Wainberg, D. Donahue, Richard Sloan, 2012, Journal of Virology.

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency

M. Wainberg, T. Mesplède, D. Donahue, 2014, Viruses.

Role of Stem B, Loop B, and Nucleotides next to the Primer Binding Site and the Kissing-Loop Domain in Human Immunodeficiency Virus Type 1 Replication and Genomic-RNA Dimerization

M. Wainberg, M. Laughrea, L. Jetté, 2001, Journal of Virology.

CRISPR/Cas9: a double-edged sword when used to combat HIV infection

A. Das, B. Berkhout, M. Wainberg, 2016, Retrovirology.

HIV-1 subtype distribution and the problem of drug resistance

M. Wainberg, Mark A Wainberg, 2004, AIDS.

Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Dan Turner, Bluma G. Brenner, M. Wainberg, 2005, Antimicrobial Agents and Chemotherapy.

Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1

A. Heredia, N. Le, M. Wainberg, 2014, AIDS.

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

M. Wainberg, M. Ntemgwa, B. Brenner, 2008, Antimicrobial Agents and Chemotherapy.

Virulence and Reduced Fitness of Simian Immunodeficiency Virus with the M184V Mutation in Reverse Transcriptase

N. Pedersen, M. Wainberg, R. Schinazi, 2002, Journal of Virology.

Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1.

S. Zolla-Pazner, M. Wainberg, E. Cherry, 1998, AIDS research and human retroviruses.

Compensation by the E 138 K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M 184 I / V Mutations

M. Wainberg, B. Brenner, P. Quashie, 2011 .

Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function

S. Richard, M. Wainberg, B. B. Roy, 2007, AIDS.

Effect of HIV constructs containing protease‐reverse transcriptase fusion proteins on viral replication

M. Wainberg, N. Morin, E. Cherry, 1998, AIDS.

HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2009, Vaccine.

Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity

M. Wainberg, J. Falgueyret, P. Quashie, 2013, Retrovirology.

The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1.

M. Wainberg, A. Dascal, M. Tremblay, 1988, Blood.

Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor

M. Wainberg, J. Hiscott, M. D'Addario, 1990, Journal of virology.

Expression, purification, and RNA-binding properties of HIV-1 p15gag nucleocapsid protein.

M. Wainberg, R. Geleziunas, L. Kleiman, 1993, Protein expression and purification.

Effects of RU486 on HIV-1 replication

M. Wainberg, H. Soudeyns, 1997, Nature Medicine.

Jewish Religious Ethics Mandate Access to Antiretroviral Drugs in Developing Countries

M. Wainberg, Shalom C. Spira, 2004, Journal of the International Association of Physicians in AIDS Care.

Deletion Mutagenesis Downstream of the 5′ Long Terminal Repeat of Human Immunodeficiency Virus Type 1 Is Compensated for by Point Mutations in both the U5 Region and gag Gene

Chen Liang, M. Wainberg, L. Rong, 2000, Journal of Virology.

Mutations within Four Distinct Gag Proteins Are Required To Restore Replication of Human Immunodeficiency Virus Type 1 after Deletion Mutagenesis within the Dimerization Initiation Site

Chen Liang, Michael Laughrea, M. Wainberg, 1999, Journal of Virology.

Deletion Mutagenesis within the Dimerization Initiation Site of Human Immunodeficiency Virus Type 1 Results in Delayed Processing of the p2 Peptide from Precursor Proteins

M. Wainberg, L. Rong, L. Kleiman, 1999, Journal of Virology.

Characterization of a Putative α-Helix across the Capsid-SP1 Boundary That Is Critical for the Multimerization of Human Immunodeficiency Virus Type 1 Gag

M. Wainberg, L. Kleiman, C. Liang, 2002, Journal of Virology.

The M184V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus

M. Wainberg, J. Whitney, Maureen Oliveira, 2002, Journal of Virology.

The M 184 V Mutation in Reverse Transcriptase Can Delay Reversion of Attenuated Variants of Simian Immunodeficiency Virus

M. Wainberg, J. Whitney, Maureen Oliveira, 2002 .

Partial Restoration of Replication of Simian Immunodeficiency Virus by Point Mutations in either the Dimerization Initiation Site (DIS) or Gag Region after Deletion Mutagenesis within the DIS

M. Wainberg, C. Liang, J. Whitney, 2001, Journal of Virology.

Roles of the Human Immunodeficiency Virus Type 1 Nucleocapsid Protein in Annealing and Initiation versus Elongation in Reverse Transcription of Viral Negative-Strand Strong-Stop DNA

M. Wainberg, B. Roques, L. Rong, 1998, Journal of Virology.

Structural changes in the SL5 and SL6 leader sequences of HIV-1 RNA following interactions with the viral mGag protein.

M. Wainberg, C. Liang, A. Roldán, 2011, Virus research.

Sequences Downstream of the 5′ Splice Donor Site Are Required for both Packaging and Dimerization of Human Immunodeficiency Virus Type 1 RNA

M. Wainberg, L. Kleiman, C. Liang, 2003, Journal of Virology.

Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome

M. Wainberg, J. Whitney, 2007, Retrovirology.

HIV-1 Nucleocapsid Protein and the Secondary Structure of the Binary Complex Formed between tRNALys.3 and Viral RNA Template Play Different Roles during Initiation of (−) Strand DNA Reverse Transcription*

M. Wainberg, B. Roques, Xiaofeng Guo, 2001, The Journal of Biological Chemistry.

Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, Canada

M. Wainberg, B. Brenner, M. Blais, 2016, AIDS and Behavior.

Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride

M. Wainberg, B. Spira, G. Bleau, 1990, Journal of clinical microbiology.

The need to promote public health in the field of illicit drug use

M. Wainberg, 2006, Canadian Medical Association Journal.

A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1

M. Wainberg, N. Almog, M. Kotler, 1996, Journal of virology.

Pre-Exposure Chemoprophylaxis (PREP) as an HIV Prevention Strategy

M. Wainberg, M. Youle, 2003, Journal of the International Association of Physicians in AIDS Care.

Primer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1

M. Wainberg, L. Kleiman, Y. Huang, 1997, Journal of virology.

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

M. Wainberg, Hong-tao Xu, T. Bar-Magen, 2010, AIDS.

Nucleotide and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B-Subtype Variants of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Moisi, 2004, Antimicrobial Agents and Chemotherapy.

ENHANCEMENT OF SENDAI VIRUS-MEDIATED CELL FUSION BY CUPRIC IONS

M. Wainberg, C. Howe, G. Godman, 1973, The Journal of cell biology.

Chapter 12 – Development and transmission of HIV drug resistance

M. Wainberg, G. Zaharatos, 2012 .

Inactivation ofHumanImmunodeficiency VirusType1inTissue Culture Fluid andinGenital Secretions bytheSpermicide Benzalkonium Chloride

M. Wainberg, 1990 .

Resistance Profiles to Antiretroviral Drugs in HIV-1 Drug-Naive Patients in Argentina

M. Wainberg, H. Salomón, P. Cahn, 2001, Antiviral therapy.

Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec

David A. Stephens, E. Moodie, M. Wainberg, 2017, AIDS.

Infection of cultured human fetal pancreatic islet cells by rubella virus.

M. Wainberg, K. Numazaki, H. Goldman, 1989, American journal of clinical pathology.

The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism

M. Wainberg, C. Liang, J. Wilkinson, 2011, PloS one.

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

M. Wainberg, C. Delaugerre, C. Tremblay, 2018, Open forum infectious diseases.

Significance of the L74V mutation in HIV-1 reverse transcriptase

M. Wainberg, M. Götte, 2006 .

Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro.

M. Wainberg, H. von Briesen, H. Rübsamen-Waigmann, 1999, Antiviral research.

Nonradioactive detection of retroviral-associated RNase H activity in a microplate-based, high-throughput format.

M. Wainberg, B. Marchand, M. Götte, 2002, BioTechniques.

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine

M. Wainberg, M. Ntemgwa, B. Brenner, 2007, Antimicrobial Agents and Chemotherapy.

Kinetics of Inhibition of HIV Type 1 Reverse Transcriptase-Bearing NRTI-associated Mutations by Apricitabine Triphosphate

M. Wainberg, Hong-tao Xu, Dimitrios Coutsinos, 2007, Antiviral chemistry & chemotherapy.

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes.

M. Wainberg, C. Tremblay, M. Ntemgwa, 2010, Antiviral research.

3′-Azido-3′-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants

Eric J. Arts, M. Wainberg, E. Arts, 1998, Journal of Virology.

Identification of novel mutations that confer drug resistance in the human immunodeficiency virus polymerase gene.

M A Wainberg, M. Wainberg, B. Brenner, 1994, Leukemia.

A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1

M. Wainberg, B. Brenner, D. Moisi, 2011, PloS one.

Factors Affecting Template Usage in the Development of K65R Resistance in Subtype C Variants of HIV Type-1

M. Wainberg, B. Brenner, Hong-tao Xu, 2010, Antiviral chemistry & chemotherapy.

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

M. Wainberg, B. Brenner, D. Moisi, 2009, Antimicrobial Agents and Chemotherapy.

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Moisi, 2008, Journal of Virology.

differential development of resistance to nelfinavir, lopinavir and atazanavir in different

M. Wainberg, Maureen Oliveira, Susan M. Schader, 2010 .

Reversible interference with TCGF activity by virus particles.

M. Wainberg, B. Spira, R. Margolese, 1984, Clinical and experimental immunology.

Human immunodeficiency virus, genital ulcers and the male foreskin: synergism in HIV-1 transmission.

M. Wainberg, F. Plummer, L. D'costa, 1990, Scandinavian journal of infectious diseases. Supplementum.

The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by Human Immunodeficiency Virus Type 1 Vpu

M. Wainberg, L. Rong, Fei Guo, 2009, Journal of Virology.

The emergence of HIV resistance and new antiretrovirals: are we winning?

M. Wainberg, 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Enhancement of avian sarcoma virus-induced tumor growth after pretreatment with BCG

M. Wainberg, E. Israèl, 1978, Infection and immunity.

Viral infection of human fetal islets of Langerhans. Replication of human cytomegalovirus in cultured human fetal pancreatic islets.

M. Wainberg, K. Numazaki, H. Goldman, 1988, American journal of clinical pathology.

Differential susceptibility of human lymphocyte cultures to infection by HIV.

M. Wainberg, L. Fitz‐Gibbon, N. Blain, 1987, Clinical and experimental immunology.

Why are there so many myths about AIDS?

M. Wainberg, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada.

M. Wainberg, M. Ntemgwa, B. Brenner, 2008, AIDS research and human retroviruses.

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review

M. Wainberg, M. Bhargava, N. Pai, 2014, Journal of the International AIDS Society.

Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity.

M. Wainberg, T. Mesplède, R. Fusco, 2016, The Journal of antimicrobial chemotherapy.

Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity

M. Wainberg, T. Mesplède, R. Fusco, 2015, Journal of Virology.

The effects of T-cell growth factor and virus purification on virus-mediated inhibition of lymphocyte mitogenesis.

M. Wainberg, R. Margolese, 1982, Clinical and experimental immunology.

Maraviroc in Early HIV Disease

M. Wainberg, J. Martínez-Cajas, 2008 .

HIV-1 Group O Integrase Displays Lower Enzymatic Efficiency and Higher Susceptibility to Raltegravir than HIV-1 Group M Subtype B Integrase

M. Wainberg, B. Brenner, D. Moisi, 2014, Antimicrobial Agents and Chemotherapy.

The inhibitory effects of suramin on HIV-1 are attenuated in the presence of albumin.

M. Wainberg, X. Yao, M. Pollak, 1991, AIDS.

HIV resistance to antiviral drugs: public health implications.

M. Wainberg, D. Cameron, 1998, Drug resistance updates.

AIDS: Drugs that prevent HIV infection

M. Wainberg, 2011, Nature.

HIV drug resistance against strand transfer integrase inhibitors

M. Wainberg, B. Brenner, T. Mesplède, 2017, Retrovirology.

HIV–1 resistance to dolutegravir: update and new insights

M. Wainberg, Yingshan Han, 2015, Journal of virus eradication.

Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes

M. Wainberg, D. Phaneuf, L. Mercure, 1995, Clinical and diagnostic laboratory immunology.

XMRV as a Human Pathogen?

M. Wainberg, K. Jeang, 2011, Cell Host & Microbe.

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

M. Wainberg, S. Colby-Germinario, P. Quashie, 2015, Antimicrobial Agents and Chemotherapy.

Variant effects of non-native kissing-loop hairpin palindromes on HIV replication and HIV RNA dimerization: role of stem-loop B in HIV replication and HIV RNA dimerization.

M. Wainberg, M. Laughrea, L. Jetté, 1999, Biochemistry.

Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization

M. Wainberg, J. Mak, L. Kleiman, 1997, Journal of virology.

A Plea for Justice for Jailed Medical Workers

A. Trkola, R. Schooley, M. Lederman, 2006, Science.

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal

M. Wainberg, C. Tremblay, B. Brenner, 2004, AIDS.

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection.

M. Wainberg, B. Brenner, D. Moisi, 2011, The Journal of antimicrobial chemotherapy.

Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.

Chen Liang, M. Wainberg, B. Brenner, 2009, The Journal of infectious diseases.

Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection

M. Wainberg, C. Boucher, A. Hill, 2006, PLoS medicine.

Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.

M. Wainberg, N. Rabinovitch, J. Portnoy, 1985, Journal of Infectious Diseases.

Viral inhibition of lymphocyte mitogenesis. I. Evidence for the nonspecificity of the effect.

M. Wainberg, E. Israèl, 1980, Journal of immunology.

NF-kappaB protects HIV-1-infected myeloid cells from apoptosis.

M. Wainberg, H. Kwon, J. Hiscott, 1998, Virology.

HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity

M. Wainberg, B. Brenner, T. Mesplède, 2017, Journal of Virology.

Four new lignans from the leaves and stems of Schisandra propinqua var. sinensis

M. Wainberg, Wei‐Lie Xiao, Han-Dong Sun, 2013, Natural Products and Bioprospecting.

Association of p56lck with the cytoplasmic domain of CD4 modulates HIV‐1 expression.

M. Wainberg, M. Tremblay, R. Sékaly, 1994, The EMBO journal.

Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.

M. Wainberg, B. Brenner, D. Moisi, 2002, Antiviral research.

Criminalizing HIV transmission may be a mistake

M. Wainberg, 2009, Canadian Medical Association Journal.

Viral inhibition of lymphocyte mitogenesis: the role of macrophages as primary targets of virus-cell interaction.

M. Wainberg, E. Israèl, 1981, Journal of the Reticuloendothelial Society.

Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC.

M. Wainberg, Q. Gao, E. Faust, 1995, The Journal of general virology.

Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1

M. Wainberg, H. Salomón, M. Gelfand, 1994, Journal of clinical microbiology.

Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication

N. Sonenberg, M. Wainberg, H. Kwon, 1996, Journal of virology.

Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.

M. Wainberg, C. Kovacs, C. Tremblay, 2016, AIDS research and human retroviruses.

Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines

M. Wainberg, Yingshan Han, Victor G. Kramer, 2014, Virology Journal.

Differential responsiveness of various substrains of inbred strain 2 guinea pigs to immunotherapy with the methanol extraction residue (MER) of BCG

D. W. Weiss, M. Wainberg, R. Margolese, 1977, Cancer Immunology, Immunotherapy.

Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana.

M. Wainberg, B. Brenner, D. Moisi, 2002, Antiviral therapy.

A resveratrol analog termed 3,3′,4,4′,5,5′‐hexahydroxy‐trans‐stilbene is a potent HIV‐1 inhibitor

M. Wainberg, T. Szekeres, W. Jaeger, 2015, Journal of medical virology.

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study

M. Wainberg, B. Brenner, Nathan Osman, 2017, AIDS Research and Therapy.

Impact of Human Immunodeficiency Virus Type 1 Subtype C on Drug Resistance Mutations in Patients from Botswana Failing a Nelfinavir-Containing Regimen

M. Wainberg, B. Brenner, I. Thior, 2006, Antimicrobial Agents and Chemotherapy.

Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients

W. Wester, M. Wainberg, I. Thior, 2004, Antiviral chemistry & chemotherapy.

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes

M. Wainberg, Hong-tao Xu, T. Bar-Magen, 2009, Retrovirology.

Construction and In Vitro Properties of a Series of Attenuated Simian Immunodeficiency Viruses with All Accessory Genes Deleted

M. Wainberg, J. Whitney, Y. Guan, 2001, Journal of Virology.

Antiretroviral Therapy

M. Wainberg, Mark A Wainberg, Jorge L Martinez-Cajas, 2008, Drugs.

The 20th International AIDS Conference: where do we go from here?

M. Wainberg, P. Sow, S. Kippax, 2014, Journal of the International AIDS Society.

Roles of Pr55gag and NCp7 in tRNA3Lys Genomic Placement and the Initiation Step of Reverse Transcription in Human Immunodeficiency Virus Type 1

Shan Cen, M. Wainberg, L. Rong, 2000, Journal of Virology.

The Role of Pr55gag in the Annealing of tRNA3Lys to Human Immunodeficiency Virus Type 1 Genomic RNA

M. Wainberg, J. Darlix, L. Kleiman, 1999, Journal of Virology.

Virus Type 1 Transcription in Human Immunodeficiency Placement and Initiation of Reverse Loop Sequences in tRNA3 Lys Genomic The Role of Nucleocapsid and U5 Stem/A-Rich

M. Wainberg, J. Darlix, Xuguang Li, 2013 .

Roles of Pr 55 gag and NCp 7 in tRNA 3 Lys Genomic Placement and the Initiation Step of Reverse Transcription in Human Immunodeficiency Virus Type 1

M. Wainberg, L. Rong, L. Kleiman, 2000 .

Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.

M. Wainberg, N. Morin, E. Cherry, 1998, Journal of Human Virology.

Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1.

M. Wainberg, L. Rong, L. Kleiman, 2000, Journal of virology.

Variable tRNA content in HIV-1IIIB.

M. Wainberg, J. Mak, L. Kleiman, 1992, Biochemical and biophysical research communications.

Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases.

M. Wainberg, R. Goody, E. Arts, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

M. Wainberg, C. Tremblay, B. Brenner, 2010, Antimicrobial Agents and Chemotherapy.

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

M. Wainberg, B. Brenner, D. Moisi, 2002, Antimicrobial Agents and Chemotherapy.

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes

M. Wainberg, T. Bar-Magen, D. Donahue, 2010, Retrovirology.

Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture

M. Wainberg, T. Bar-Magen, Susan M. Schader, 2009, Antimicrobial Agents and Chemotherapy.

Envelope V3 region sequences of Cuban HIV-1 isolates.

M. Wainberg, J. Mato, F. Rolo, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

Mark Holodniy, Robert W Shafer, Daniel R Kuritzkes, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of zidovudine-resistant variants of HIV-1 in genital fluids.

M. Wainberg, C. Tsoukas, R. Beaulieu, 1993, AIDS (London).

We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.

M. Wainberg, B. Brenner, 2016, AIDS.

Is Drug Resistance in First-Line Therapy against All Antiretroviral Agents Inevitable?

M. Wainberg, Thibault Mespl de, 2015 .

World AIDS Day: together we will stop HIV transmission and conquer AIDS

M. Wainberg, A. Lever, 2013, Retrovirology.

Proof of principle: antiretroviral drugs can prevent sexual transmission of HIV-1

M. Wainberg, H. Field, 2011 .

Generic HIV drugs--enlightened policy for global health.

M. Wainberg, 2005, The New England journal of medicine.

Multiple choices for HIV therapy with integrase strand transfer inhibitors

M. Wainberg, F. Raffi, 2012, Retrovirology.

The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites.

M. Wainberg, B. Brenner, D. Moisi, 2013, The Journal of antimicrobial chemotherapy.

Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1.

M. Wainberg, J. Hiscott, R. Geleziunas, 1991, AIDS.

High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C Isolates from Infected Patients in Botswana Treated with Didanosine-Based Regimens

M. Wainberg, B. Brenner, M. Mine, 2006, Antimicrobial Agents and Chemotherapy.

, M multiplication . type 1 gene expression and virus activation of human immunodeficiency virus block Tat-tumor necrosis factor synergistic Transdominant mutants of I kappa B alpha

N. Sonenberg, M. Wainberg, H. Kwon, 1996 .

Multiple choices for HIV therapy with integrase strand transfer inhibitors

M. Wainberg, F. Raffi, 2012, Retrovirology.

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA

M. Wainberg, Fei Guo, C. Liang, 2015, Retrovirology.

Opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: report of two cases.

M. Wainberg, R. Lalonde, P. René, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Multiple forms of tRNA(Lys3) in HIV-1.

M. Wainberg, E. Arts, J. Mak, 1996, Biochemical and biophysical research communications.

Development of an Allele-Specific PCR for Detection of the K65R Resistance Mutation in Patients Infected with Subtype C Human Immunodeficiency Virus Type 1

M. Wainberg, M. Ntemgwa, B. Brenner, 2009, Antimicrobial Agents and Chemotherapy.

In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Novel Protease Inhibitor of Human Immunodeficiency Virus Type 1

M. Wainberg, J. Schapiro, N. Parkin, 2007, Antimicrobial Agents and Chemotherapy.

Pre-exposure prophylaxis against HIV: pros and cons

M. Wainberg, 2012, Retrovirology.

Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs

M. Wainberg, S. Fafi-Kremer, T. Mesplède, 2018, The Journal of antimicrobial chemotherapy.

[HIV drug resistance and optimization of antiviral treatment in resource-poor countries].

M. Wainberg, B. Brenner, D. Turner, 2004, Medecine sciences : M/S.

Infection of human monocyte‐derived macrophages by human immunodeficiency virus mediated by cell‐to‐cell transmission

M. Wainberg, E. Arts, R. Geleziunas, 1993, Journal of medical virology.

At the forefront of retrovirology research: Frontiers of Retrovirology

M. Wainberg, T. Bar-Magen, Richard Sloan, 2010 .

In HIV‐infected individuals who desire combination antiviral therapy, zidovudine plus didanosine is preferred to zidovudine plus zalcitabine

M. Wainberg, J. Montaner, M. O'shaughnessy, 1994 .

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B

M. Wainberg, P. Quashie, Nathan Osman, 2015, AIDS.

Didanosine Compared with Continued Zidovudine Therapy for HIV-Infected Patients with 200 to 500 CD4 Cells/mm3: A Double-Blind, Randomized, Controlled Trial

M. Wainberg, M. Schechter, H. Salomón, 1995, Annals of Internal Medicine.

New Securinega alkaloids with anti-HIV activity from Flueggea virosa

M. Wainberg, Yingshan Han, J. Yue, 2015 .

Flueggethers B–D, Securinega alkaloids with rare oligomerizing pattern from Flueggea virosa

M. Wainberg, Yingshan Han, J. Yue, 2016 .

Anti-HIV Securinega alkaloid oligomers from Flueggea virosa

M. Wainberg, Yingshan Han, J. Yue, 2015 .

Virus induction of NF-kappa B/Rel proteins and type I interferon gene expression in myelomonoblastic cells.

M. Wainberg, J. Hiscott, A. Roulston, 1994, Leukemia.

The XVI International Conference on AIDS: The place to be!

M. Wainberg, 2006, Retrovirology.

Incorporation of tRNA into normal and mutant HIV-1.

M. Wainberg, L. Kleiman, M. Parniak, 1991, Biochemical and biophysical research communications.

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.

M. Wainberg, B. Brenner, D. Moisi, 2012, The Journal of antimicrobial chemotherapy.

immunodeficiency virus type 1 The effect of cyclosporine A on infection of susceptible cells by human

M. Wainberg, A. Dascal, M. Tremblay, 2008 .

HIV and Zika: When will we be able to end these epidemics?

M. Wainberg, A. Lever, 2016, Retrovirology.

Effect of mutations in NC7 on endogenous reverse transcription in HIV-1

M. Wainberg, L. Kleiman, E. Cherry, 1999, Leukemia.

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication#

M. Wainberg, S. Colby-Germinario, Nathan Osman, 2017, Scientific Reports.

HIV-1 Group O Resistance Against Integrase Inhibitors

M. Wainberg, B. Brenner, D. Moisi, 2015, Journal of Acquired Immune Deficiency Syndromes.

Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG

D. W. Weiss, M. Wainberg, V. Deutsch, 1976, British Journal of Cancer.

In vitro correlates of clinical response to methotrexate in actue leukaemia and Burkitt's lymphoma.

D. W. Weiss, M. Wainberg, V. Deutsch, 1976, British Journal of Cancer.

Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 “Deep” Sequencing

Jeffrey N. Martin, P. Harrigan, M. Wainberg, 2012, PLoS ONE.

PL‐100, a novel HIV‐1 protease inhibitor displaying a high genetic barrier to resistance: An in vitro selection study

M. Wainberg, C. Coburn, M. Holloway, 2008, Journal of medical virology.

Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice

M. Wainberg, J. Garcia, D. Powell, 2010, PloS one.

HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).

M. Wainberg, M. Parniak, D. Arion, 1996, Biochemical and biophysical research communications.

HIV and Ebola: similarities and differences

M. Wainberg, P. Sow, S. Kippax, 2014, Journal of the International AIDS Society.

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.

J. Montaner, M. Wainberg, J. Ruedy, 1995, The Journal of infectious diseases.

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse 1

M. Wainberg, Richard Sloan, L. Cécile, 2012 .

False-positive results of confirmatory testing for antibody to HIV-I.

M. Wainberg, B. Spira, S. Roy, 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Need for caution in interpretation of Western Blot tests for HIV.

M. Wainberg, S. Roy, J. Portnoy, 1987, JAMA.

Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity

M. Wainberg, J. Falgueyret, P. Quashie, 2013, Retrovirology.

Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells.

M. Wainberg, H. Kwon, J. Hiscott, 1998, Journal of Biological Chemistry.

Mature reverse transcriptase (p66/p51) is responsible for low levels of viral DNA found in human immunodeficiency virus type 1 (HIV-1).

M. Wainberg, E. Arts, J. Mak, 1994, Leukemia.

Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.

M. Wainberg, Xuguang Li, Jiong Wu, 1993, Journal of Biological Chemistry.

Jean-Luc Darlix: Renaissance scientist and retrovirologist par excellence

M. Wainberg, É. Cohen, 2011, Retrovirology.

Biochemical mechanism of clinical resistance to rilpivirine

M. Wainberg, S. Sarafianos, D. Rai, 2012, BMC Infectious Diseases.

Effect of phorbol ester on growth of tumors induced by Rous sarcoma virus and on pp60src kinase activity in these tumors.

M. Wainberg, V. Skalski, L. Poulin, 1987, Cancer Research.

Sugar transport and glut transporter expression in a variety of human immunodeficiency virus-1 (HIV-1) chronically infected target cell lines.

M. Wainberg, B. Brenner, R. Germinario, 1998, The international journal of biochemistry & cell biology.

Effect of prior inoculation with chemical carcinogens on development of avian retrovirus-induced neoplasia in chickens.

M. Wainberg, P. Rohan, 1980, British Journal of Cancer.

Plasminogen activator is an apparent lymphocyte mitogen.

M. Wainberg, S. Cohen, E. Israèl, 1981, Journal of immunology.

Handbook of Antimicrobial Resistance

M. Wainberg, A. Berghuis, G. Matlashewski, 2017, Springer New York.

Development of antiretroviral drug resistance.

M. Wainberg, B. Brenner, G. Zaharatos, 2011, The New England journal of medicine.

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes.

M. Wainberg, C. Tremblay, M. Ntemgwa, 2010, Antiviral research.

Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection

J. Montaner, M. Wainberg, D. Kuritzkes, 2005, Antiviral therapy.

Further studies on the mitogenic and immune-modulating effects of plasminogen activator.

M. Wainberg, R. Margolese, E. Israèl, 1982, Immunology.

CSCI Young Investigators Forum Abstracts

M. Wainberg, B. Brenner, D. Moisi, 2009 .

M. Wainberg, S. Colby-Germinario, Yingshan Han, 2013, Journal of Virology.

Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors

M. Wainberg, P. Quashie, T. Mesplède, 2014, AIDS.

First report of HIV-2 infection in Argentina.

M. Wainberg, H. Salomón, E. Rud, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination

M. Wainberg, S. Colby-Germinario, Hong-tao Xu, 2011, AIDS.

The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites.

M. Wainberg, B. Brenner, D. Moisi, 2013, The Journal of antimicrobial chemotherapy.

HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity

M. Wainberg, B. Brenner, T. Mesplède, 2017, Journal of Virology.

Differences among HIV-1 subtypes in drug resistance against integrase inhibitors.

M. Wainberg, Yingshan Han, T. Mesplède, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

HIV-1 Resistance to Integrase Inhibitors

M. Wainberg, Yingshan Han, T. Mesplède, 2017 .

Novel therapeutic strategies targeting HIV integrase

M. Wainberg, P. Quashie, Richard Sloan, 2012, BMC Medicine.

Inhibition of human lymphocyte mitogenesis by human and other retroviruses. Differential effect of interleukin-2 in restoration of responsiveness.

M. Wainberg, B. Spira, N. Blain, 1987, AIDS.

Specific stimulation of lymphocytes from patients with AIDS by herpes simplex virus antigens.

M. Wainberg, C. Tsoukas, J. Portnoy, 1987, Immunology.

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

M. Wainberg, B. Brenner, D. Moisi, 2008, Journal of Virology.

HIV-1 group O integrase displays lower enzymatic efficiency and higher

M. Wainberg, B. Brenner, D. Moisi, 2014 .